OGN ELISA试剂盒

Seki, Saita, Kishimoto, Ibe, Miyazaki, Miura, Ohmori, Ikegami, Kondo, Momiyama: "Low Levels of Plasma Osteoglycin in Patients with Complex Coronary Lesions." in: Journal of atherosclerosis and thrombosis, Vol. 25, Issue 11, pp. 1149-1155, (2019) (PubMed).

Baek, Cha, Kang, Park, Cha, Kim, Yoon, Kim, Han, Park, Chang, Lim, Kim, Na: "Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease." in: The Tohoku journal of experimental medicine, Vol. 242, Issue 4, pp. 281-290, (2018) (PubMed).

Hu, Li, Li, Ma, Peng, Cai: "Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway." in: Journal of experimental & clinical cancer research : CR, Vol. 37, Issue 1, pp. 41, (2018) (PubMed).

Lee, Ali, Zhang, Qi, Clarke, Enriquez, Brzozowska, Lee, Rogers, Laybutt, Center, Baldock, Herzog: "Osteoglycin, a novel coordinator of bone and glucose homeostasis." in: Molecular metabolism, Vol. 13, pp. 30-44, (2018) (PubMed).

Yang, Wu, Li, Gao: "Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients." in: Journal of human hypertension, Vol. 32, Issue 8-9, pp. 564-571, (2018) (PubMed).

Tanaka, Kanazawa, Kaji, Sugimoto: "Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus." in: Bone, Vol. 95, pp. 5-10, (2016) (PubMed).

Van Aelst, Voss, Carai, van Leeuwen, Vanhoutte, Sanders-van Wijk, Eurlings, Swinnen, Verheyen, Verbeken, Nef, Troidl, Cook, Brunner-La Rocca, Möllmann, Papageorgiou, Heymans: "Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening." in: Circulation research, (2014) (PubMed).